Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Karyopharm Therapeutics Inc. (KPTI)  
$0.96 0.01 (1.31%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 113,340,000
Market Cap: 108.83(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6758 - $2.34
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 41,140 41,140
Total Buy Value $0 $0 $49,985 $49,985
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 1,742,394 1,991,983 2,034,743 2,166,102
Total Sell Value $1,686,502 $1,983,691 $2,040,821 $2,489,187
Total People Sold 4 7 7 8
Total Sell Transactions 11 29 39 62
End Date 2024-03-12 2023-12-10 2023-06-11 2022-06-11

   
Records found: 620
  Page 8 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Primiano Christopher Brett EVP, CBO, GC & Secretary   •       –      –    2020-12-01 4 OE $10.39 $1,428,751 D/D 137,061 63,460     -
   Primiano Christopher Brett EVP, CBO, GC & Secretary   •       –      –    2020-11-02 4 AS $14.92 $11,518 D/D (772) 4,523 -13%     
   Lewis Tanya EVP,Chief Reg.&Quality Officer   •       –      –    2020-10-30 4 S $15.58 $3,521 D/D (226) 539 17%     
   Lewis Tanya EVP,Chief Reg.&Quality Officer   •       –      –    2020-10-28 4 OE $0.00 $0 D/D 765 765     -
   Primiano Christopher Brett EVP, CBO, GC & Secretary   •       –      –    2020-10-13 4 AS $16.85 $661,969 D/D (39,271) 4,649 -7%     
   Primiano Christopher Brett EVP, CBO, GC & Secretary   •       –      –    2020-10-13 4 OE $9.21 $362,537 D/D 39,271 5,370     -
   Kauffman Michael Chief Executive Officer   •       •      –    2020-10-12 4 AS $14.89 $111,683 I/I (7,500) 756,489 -1%     
   Kauffman Michael Chief Executive Officer   •       •      –    2020-10-12 4 OE $0.03 $248 I/I 7,500 763,989     -
   Shacham Sharon President & CSO   •       –      –    2020-10-12 4 AS $14.89 $111,683 D/D (7,500) 756,489 -1%     
   Shacham Sharon President & CSO   •       –      –    2020-10-12 4 OE $0.03 $248 D/D 7,500 763,989     -
   Primiano Christopher Brett EVP, CBO, GC & Secretary   •       –      –    2020-09-08 4 AS $14.98 $150,609 D/D (10,054) 4,649 4%     
   Primiano Christopher Brett EVP, CBO, GC & Secretary   •       –      –    2020-09-08 4 OE $6.54 $65,753 D/D 10,054 14,703     -
   Demaree John Chief Commercial Officer   •       –      –    2020-08-26 4 B $14.54 $109,013 D/D 7,500 7,500 2.74 24%     
   Shacham Sharon President & CSO   •       –      –    2020-08-17 4 AS $15.00 $22,155 D/D (1,477) 756,489 -3%     
   Shacham Sharon President & CSO   •       –      –    2020-08-17 4 OE $0.03 $49 D/D 1,477 757,966     -
   Kauffman Michael Chief Executive Officer   •       •      –    2020-08-17 4 AS $15.00 $22,155 I/I (1,477) 756,489 -3%     
   Kauffman Michael Chief Executive Officer   •       •      –    2020-08-17 4 OE $0.03 $49 I/I 1,477 757,966     -
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2020-07-15 4 S $19.46 $11,462 D/D (589) 43,229 22%     
   Shacham Sharon President & CSO   •       –      –    2020-07-15 4 AS $19.43 $145,723 D/D (7,500) 756,489 -22%     
   Shacham Sharon President & CSO   •       –      –    2020-07-15 4 OE $0.03 $248 D/D 7,500 763,989     -
   Kauffman Michael Chief Executive Officer   •       •      –    2020-07-15 4 AS $19.43 $145,723 I/I (7,500) 756,489 -22%     
   Kauffman Michael Chief Executive Officer   •       •      –    2020-07-15 4 OE $0.03 $248 I/I 7,500 763,989     -
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2020-07-11 4 OE $0.00 $0 D/D 2,413 43,172     -
   Kauffman Michael Chief Executive Officer   •       •      –    2020-06-22 4 AS $20.00 $150,000 I/I (7,500) 756,489 -24%     
   Kauffman Michael Chief Executive Officer   •       •      –    2020-06-22 4 OE $0.03 $248 I/I 7,500 763,989     -
  620 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us